MicroRNAs As Regulators of Immune and Inflammatory Responses: Potential Therapeutic Targets in Diabetic Nephropathy

Overview

Journal Front Cell Dev Biol

Specialty Cell Biology

Date 2021 Feb 11

PMID 33569382

Citations 27

Authors

Hong Zhou

Wei-Jian Ni

Xiao-Ming Meng

Li-Qin Tang

Affiliations

Soon will be listed here.

Abstract

Diabetic nephropathy (DN) is the principal cause of end-stage renal disease and results in high morbidity and mortality in patients, causing a large socioeconomic burden. Multiple factors, such as metabolic abnormalities, inflammation, immunoregulation and genetic predisposition, contribute to the pathogenesis of DN, but the exact mechanism is unclear, and the therapeutic strategies are not satisfactory. Accordingly, there is an unmet need for new therapeutic targets and strategies for DN. MicroRNAs (miRNAs) act as major epigenetic mechanisms that regulate gene expression and provide novel insights into our understanding of the molecular and signaling pathways that are associated with various diseases, including DN. Studies in the past decade have shown that different miRNAs affect the progression of DN by modulating different aspects of immune and inflammatory responses. Therefore, in this review, we summarized the pivotal roles of miRNAs in inflammatory and immune processes, with an integrative comprehension of the detailed signaling network. Additionally, we discussed the possibilities and significance of these miRNAs as therapeutic targets in the treatment of DN. This review will facilitate the identification of new therapeutic targets and novel strategies that can be translated into clinical applications for DN treatment.

Citing Articles

Long noncoding RNA Gm4419 promotes mesangial cell proliferation and extracellular matrix accumulation the miR-455-3p/histone deacetylase 2 axis.

Wen Y, Gan H, Zhong Q, Gong Y Heliyon. 2025; 11(1):e38835.

PMID: 39758407 PMC: 11699353. DOI: 10.1016/j.heliyon.2024.e38835.

The functions of immune system-derived miRNAs in cardiovascular diseases.

Sufianov A, Agaverdiev M, Mashkin A, Ilyasova T Noncoding RNA Res. 2024; 11:91-103.

PMID: 39736852 PMC: 11683256. DOI: 10.1016/j.ncrna.2024.11.004.

The immune-inflammation factor is associated with diabetic nephropathy: evidence from NHANES 2013-2018 and GEO database.

Wang Y, Zhao S, Wang Y, Xu J, Wang J Sci Rep. 2024; 14(1):17760.

PMID: 39085362 PMC: 11291652. DOI: 10.1038/s41598-024-68347-1.

Pathological mechanism of immune disorders in diabetic kidney disease and intervention strategies.

Zhou T, Fang Y, Tian T, Wang G World J Diabetes. 2024; 15(6):1111-1121.

PMID: 38983817 PMC: 11229953. DOI: 10.4239/wjd.v15.i6.1111.

Epigenetics of hypertension as a risk factor for the development of coronary artery disease in type 2 diabetes mellitus.

Karabaeva R, Vochshenkova T, Mussin N, Albayev R, Kaliyev A, Tamadon A Front Endocrinol (Lausanne). 2024; 15:1365738.

PMID: 38836231 PMC: 11148232. DOI: 10.3389/fendo.2024.1365738.

References

Baker M, Davis S, Liu P, Pan X, Williams A, Iczkowski K . Tissue-Specific MicroRNA Expression Patterns in Four Types of Kidney Disease. J Am Soc Nephrol. 2017; 28(10):2985-2992. PMC: 5619963. DOI: 10.1681/ASN.2016121280. View

Lee E, Valencia T, Allerson C, Schairer A, Flaten A, Yheskel M . Discovery and preclinical evaluation of anti-miR-17 oligonucleotide RGLS4326 for the treatment of polycystic kidney disease. Nat Commun. 2019; 10(1):4148. PMC: 6742637. DOI: 10.1038/s41467-019-11918-y. View

Fornari T, Donate P, Assis A, Macedo C, Sakamoto-Hojo E, Donadi E . Comprehensive Survey of miRNA-mRNA Interactions Reveals That Ccr7 and Cd247 (CD3 zeta) are Posttranscriptionally Controlled in Pancreas Infiltrating T Lymphocytes of Non-Obese Diabetic (NOD) Mice. PLoS One. 2015; 10(11):e0142688. PMC: 4659659. DOI: 10.1371/journal.pone.0142688. View

Gordon S, Martinez F . Alternative activation of macrophages: mechanism and functions. Immunity. 2010; 32(5):593-604. DOI: 10.1016/j.immuni.2010.05.007. View

Arora S, Dev K, Agarwal B, Das P, Syed M . Macrophages: Their role, activation and polarization in pulmonary diseases. Immunobiology. 2017; 223(4-5):383-396. PMC: 7114886. DOI: 10.1016/j.imbio.2017.11.001. View

Huang Y, Liu Y, Li L, Su B, Yang L, Fan W . Involvement of inflammation-related miR-155 and miR-146a in diabetic nephropathy: implications for glomerular endothelial injury. BMC Nephrol. 2014; 15:142. PMC: 4236663. DOI: 10.1186/1471-2369-15-142. View

Gu X, Wang X, Lin M, Liang H, Fan S, Wang L . Molecular interplay between microRNA-130a and PTEN in palmitic acid-mediated impaired function of endothelial progenitor cells: Effects of metformin. Int J Mol Med. 2019; 43(5):2187-2198. DOI: 10.3892/ijmm.2019.4140. View

Gholaminejad A, Tehrani H, Fesharaki M . Identification of candidate microRNA biomarkers in diabetic nephropathy: a meta-analysis of profiling studies. J Nephrol. 2018; 31(6):813-831. DOI: 10.1007/s40620-018-0511-5. View

Runtsch M, Nelson M, Lee S, Voth W, Alexander M, Hu R . Anti-inflammatory microRNA-146a protects mice from diet-induced metabolic disease. PLoS Genet. 2019; 15(2):e1007970. PMC: 6395003. DOI: 10.1371/journal.pgen.1007970. View

10.

Lv L, Feng Y, Wu M, Wang B, Li Z, Zhong X . Exosomal miRNA-19b-3p of tubular epithelial cells promotes M1 macrophage activation in kidney injury. Cell Death Differ. 2019; 27(1):210-226. PMC: 7206053. DOI: 10.1038/s41418-019-0349-y. View

11.

Kabekkodu S, Shukla V, Varghese V, D Souza J, Chakrabarty S, Satyamoorthy K . Clustered miRNAs and their role in biological functions and diseases. Biol Rev Camb Philos Soc. 2018; 93(4):1955-1986. DOI: 10.1111/brv.12428. View

12.

Kim Y, Lim J, Kim M, Kim E, Yoon H, Shin S . The Adiponectin Receptor Agonist AdipoRon Ameliorates Diabetic Nephropathy in a Model of Type 2 Diabetes. J Am Soc Nephrol. 2018; 29(4):1108-1127. PMC: 5875945. DOI: 10.1681/ASN.2017060627. View

13.

Zheng Y, Ley S, Hu F . Global aetiology and epidemiology of type 2 diabetes mellitus and its complications. Nat Rev Endocrinol. 2017; 14(2):88-98. DOI: 10.1038/nrendo.2017.151. View

14.

Bhatt K, Lanting L, Jia Y, Yadav S, Reddy M, Magilnick N . Anti-Inflammatory Role of MicroRNA-146a in the Pathogenesis of Diabetic Nephropathy. J Am Soc Nephrol. 2015; 27(8):2277-88. PMC: 4978034. DOI: 10.1681/ASN.2015010111. View

15.

Tarabra E, Giunti S, Barutta F, Salvidio G, Burt D, Deferrari G . Effect of the monocyte chemoattractant protein-1/CC chemokine receptor 2 system on nephrin expression in streptozotocin-treated mice and human cultured podocytes. Diabetes. 2009; 58(9):2109-18. PMC: 2731530. DOI: 10.2337/db08-0895. View

16.

Haneklaus M, Gerlic M, ONeill L, Masters S . miR-223: infection, inflammation and cancer. J Intern Med. 2013; 274(3):215-26. PMC: 7166861. DOI: 10.1111/joim.12099. View

17.

Sheikhansari G, Soltani-Zangbar M, Pourmoghadam Z, Kamrani A, Azizi R, Aghebati-Maleki L . Oxidative stress, inflammatory settings, and microRNA regulation in the recurrent implantation failure patients with metabolic syndrome. Am J Reprod Immunol. 2019; 82(4):e13170. DOI: 10.1111/aji.13170. View

18.

Leiss H, Salzberger W, Jacobs B, Gessl I, Kozakowski N, Bluml S . MicroRNA 155-deficiency leads to decreased autoantibody levels and reduced severity of nephritis and pneumonitis in pristane-induced lupus. PLoS One. 2017; 12(7):e0181015. PMC: 5515414. DOI: 10.1371/journal.pone.0181015. View

19.

Sun D, Chen J, Wu W, Tang J, Luo L, Zhang K . MiR-802 causes nephropathy by suppressing NF-κB-repressing factor in obese mice and human. J Cell Mol Med. 2019; 23(4):2863-2871. PMC: 6433720. DOI: 10.1111/jcmm.14193. View

20.

Yang J, Liao X, Agarwal M, Barnes L, Auron P, Stark G . Unphosphorylated STAT3 accumulates in response to IL-6 and activates transcription by binding to NFkappaB. Genes Dev. 2007; 21(11):1396-408. PMC: 1877751. DOI: 10.1101/gad.1553707. View